menu search

These up-and-coming stocks are screaming buys right now

axsome launched its first products last year -- and others may be on the horizon. CRISPR recently compl...

April 13, 2023, 5:30 am

Can axsome hold out till depression drug becomes a blockbuster?

Auvelity, a drug newly approved for major depressive disorder, could exceed $1 billion in sales by 2029. Analysts still expect ...

April 12, 2023, 8:35 am

A new nasdaq bull market is nearly here: 3 stocks to buy sooner rather than later

axsome Therapeutics has multiple catalysts on the way. MercadoLibre is already in a bull market of its ...

April 8, 2023, 5:52 am

Has axsome therapeutics become a no-brainer buy?

axsome's revenue topped $50 million last year as Sunosi and Auvelity gave the biotech some momentum. Th...

April 5, 2023, 9:45 am

Why agenus, amarin, and axsome therapeutics shares slumped today

Two economic reports point to a possible recession later this year. Investors sold off risky biotech stocks as a result....

April 4, 2023, 3:53 pm

3 surprisingly underrated stocks to buy in april

axsome Therapeutics has multiple catalysts on the way. Johnson & Johnson is a bargain with its improvin...

April 1, 2023, 6:14 am

axsome (axsm) stock up 17% in six months: here's why

axsome's (AXSM) shares have surged 17.2% in the past six months, owing to the launch of its first produ...

March 20, 2023, 1:46 pm

axsome therapeutics: symphony catalyst unlocking

Given that axsome Therapeutics, Inc. is launching Auvelity with a small in-house team, you can expect a...

March 9, 2023, 2:52 pm

Is axsome therapeutics stock a buy now?

axsome Therapeutics' current portfolio could generate over $3 billion in peak annual sales. However, th...

March 6, 2023, 6:15 am

axsome (axsm) q4 earnings miss, auvelity records first sales

axsome Therapeutics (AXSM) incurs wider-than-expected loss in Q4 2022. Revenues beat estimates while sh...

February 28, 2023, 3:49 pm

axsome therapeutics (axsm) reports q4 loss, tops revenue estimates

axsome (AXSM) delivered earnings and revenue surprises of -8.47% and 13.29%, respectively, for the quar...

February 27, 2023, 9:47 am

axsome: teva's anda is no surprise and no big deal

Teva filed an ANDA challenge against Auvelity four months after approval. The filing defines, for me, the hurdles generics will face in challenging ...

February 20, 2023, 11:06 am

: axsome’s stock falls after disclosing teva’s plans to market generic auvelity

Shares of axsome Therapeutics Inc. AXSM tumbled about 10.0% in premarket trading on Monday after the co...

February 13, 2023, 1:01 pm

axsome therapeutics (axsm) stock falls as teva pursues generic depression drug

axsome Therapeutics (NASDAQ: AXSM ) stock is taking a beating on Monday as rival Teva Pharmaceutical (N...

February 13, 2023, 10:34 am

axsome's stock falls after disclosing teva's plans to market generic auvelity

Shares of axsome Therapeutics Inc. AXSM, -0.27% tumbled about 10.0% in premarket trading on Monday afte...

February 13, 2023, 8:01 am

axsome: a lot more upside in 2023

axsome has one pending approval and two pending NDAs coming up in 2023. They are adequately funded, if ...

January 2, 2023, 7:10 am

axsome (axsm) rides on new drug approval & sunosi buyout

axsome (AXSM) receives FDA approval for Auvelity to treat major depressive disorder in August. The Suno...

December 30, 2022, 11:17 am

Better buy: moderna vs axsome

Revenue prospects look promising for both of these biotech companies....

December 22, 2022, 5:30 am

After jumping 100%, is axsome a buy before 2023?

axsome's revenue story is just getting started....

December 16, 2022, 6:15 am

axsome: more catalysts stacking for 2023

In its early launch for depression, axsome Therapeutics, Inc.'s Auvelity is already garnering robust ma...

December 8, 2022, 12:05 pm


Search within

Pages Search Results: